Results for “midterm results”

The nationwide blue wave in the midterm election didn’t necessarily carry over to ballot measures on abortion and transgender issues.

Results from a clinical trial in five major United States cities show that delivering integrated HIV and substance use disorder (SUD) services using peer navigation in mobile medical units reduced all-cause deaths by 71% compared with those among participants who received peer navigation to community-based services alone. While scientists found no difference in the use of daily, oral preexposure prophylaxis (PrEP) and medication for opioid use disorder (MOUD) between the groups, the secondary outcome of reduced mortality was significant. The study is published in JAMA Psychiatry.

A treatment that is part of standard care for adults with acute respiratory distress syndrome does not provide the same benefit in children. Children with severe acute lung injury placed in the prone position do not spend less time dependent on a ventilator. High-frequency oscillatory ventilation does not shorten the duration of mechanical ventilation either. This is shown by a worldwide study led, among others, by UMCG pediatric intensivist Dr. Martin Kneyber. The results were published in The Lancet.

In many cases, all it takes is one mutated gene to orchestrate changes across a whole network of genes linked to autism, according to new results published in Nature by researchers at Boston Children's Hospital. The finding could explain why different mutations in one or several of the hundreds of genes linked to autism can lead to a similar condition.

Pregnant women with undiagnosed anxiety could benefit from a new digital therapy, according to a clinical trial led by King's College London. Published in JAMA Network Open, the results from the REducing Levels of AnXiety (RELAX) study have shown that self-led digital therapy significantly reduced participants' pre- and post-birth anxiety compared with participants who received usual care.

In a recent Yale-led clinical trial, a new type of prostate cancer drug showed promising results in reducing tumor activity and pain for patients with metastatic prostate cancer.

Democratic doctors were among the winners in the midterm elections, while the MAHA movement and President Trump's health agenda were losers.

Democrats gained control of both chambers of Congress, and doctors and scientists won key seats. Here are the top health takeaways from the midterms.

New research presented at TCT 2026 found similar short-term outcomes in women and men with intermediate-risk pulmonary embolism (PE) after aspiration thrombectomy, a catheter-based procedure to remove blood clots from arteries in the lungs, despite higher pretreatment risk among women. The results were simultaneously published in JSCAI.

Imagine scrolling through social media and seeing dramatic weight-loss results from people taking Mounjaro, Wegovy or Ozempic. They share photographs, discuss side effects and recommend ways to get the best results.

One patient in a small trial is experiencing the fantasy results so far with an mRNA pancreatic cancer vaccine. She shows no evidence of the cancer that was supposed to kill her years ago.

Alpha-1 antitrypsin deficiency (AATM) is a congenital metabolic disorder. It is caused by a genetic defect, which results in the protective protein alpha-1 antitrypsin (AAT) being produced incorrectly. This deficiency primarily damages the lungs and the liver, where it can lead to serious conditions such as pulmonary emphysema, liver fibrosis or cirrhosis. In particularly severe cases, an organ transplant is the last resort. There is as yet no curative treatment.

Five Bay Area labs teamed up to compare lasting effects of psilocybin on anxiety and depression-like behavior in mice, with limited results:

Researchers at Roswell Park Comprehensive Cancer Center have identified a promising strategy for overcoming one of the biggest challenges facing KRAS-targeted cancer therapies: treatment resistance. Results of the preclinical study, led by Roswell Park faculty members Vishnu Kumarasamy, Ph.D., Agnieszka Witkiewicz, M.D., and Erik Knudsen, Ph.D., were published in Cancer Research.

Experimental trials of psychedelic drugs in both humans and animals have produced conflicting results, creating doubts about whether hallucinogens have a therapeutic role in treating neurologic or behavioral disorders such as depression and PTSD.

Investors and doctors are intensely awaiting mid-stage results of an experimental Kymera therapy positioned to rival Dupixent.

The relationship between creativity and mental health has attracted the interest of many psychologists over the past decades. Some past studies have found that creativity is sometimes linked to mental health difficulties, while others collected opposing or inconsistent results.

RFK Jr. is making his pitch ahead of a midterm election that could shape the fate of his MAHA movement.

The campaign to defend access to transgender healthcare for young people in Missouri is taking an unhurried approach to talking with voters about how the ban on midterm ballots would play out.

The scientists involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.